MP35-03 INDICATIONS AND OUTCOMES OF SURGICAL TREATMENT FOR CHRONIC BACTERIAL PROSTATITIS IN A CONTEMPORARY CASE SERIES

You have accessJournal of UrologyInfections/Inflammation/Cystic Disease the Genitourinary Tract: Prostate & Genitalia (MP35)1 Sep 2021MP35-03 INDICATIONS AND OUTCOMES OF SURGICAL TREATMENT FOR CHRONIC BACTERIAL PROSTATITIS IN A CONTEMPORARY CASE SERIES Johnathan Doolittle, and Daniel Shoskes DoolittleJohnathan Doolittle More articles by this author , ShoskesDaniel View All Author Informationhttps://doi.org/10.1097/JU.0000000000002044.03AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION OBJECTIVE: Category II prostatitis or Chronic Bacterial Prostatitis (CBP) is characterized recurrent bacterial urinary tract infections with a prostatic source. While antibiotics are treatment choice, infection may not be cured in at least 40% surgery might necessary. Indications for outcomes, vary widely literature. Our objective was study our case series CBP focused on indications outcomes. METHODS: We retrospectively identified all patients undergoing surgical managed single provider over past decade. Pre-surgical variables included presence infections, species, TRUS volume, prostate stones, localizing cultures, treatment. Transurethral offered stones within capsule, total prostatectomy those cancer nidus manageable TUR. Surgery therapy, outcome, complications follow up were recorded. RESULTS: 19 mean age 67.2 years underwent from 2010 through 2019. Relevant pre post-operative data each reported Table 1. had documented despite antibiotics. Average volume 45.6cc, 8/19 patients, diagnosed 3 5 that pre-operative biopsy. 12 TURP 7 (TP) cure rate 84.2% (16/19) 36.9 months. 4/19 experienced long term treatment, including 3/7 after TP. One developed urethral stricture post operatively. CONCLUSIONS: Careful patient selection identifiable localization target concomitant resulted year up. seldom effective as “prostatitis”, careful can lead high bacteriologic rate. Source Funding: None © 2021 American Urological Association Education Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e627-e627 Advertisement Copyright Permissions© Inc.MetricsAuthor Information Expand Loading ...